Q32 Bio QTTB
NASDAQ QTTB
$8.27 -1.26 (-13.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Q32 Bio (QTTB) Debt Ratio (2023 - 2026)

Updated

Q32 Bio's Debt Ratio was 0.13 in Q1 2026, down 20.0% from 0.16 a year earlier and down 18.3% from the prior quarter.

Analysis

Q32 Bio (QTTB) Debt Ratio (2023 - 2026) Analysis & Trends

For FY2025, Debt Ratio at Q32 Bio came in at 0.16, up 14.7% from FY2024.

  • In earlier years, Debt Ratio was 0.14 in FY2024 (+18.1%) and 0.12 in FY2023.
  • The Q1 2026 figure marks the lowest quarterly Debt Ratio since Q3 2024.
  • Compared with a year earlier, Debt Ratio was higher in five of the last six quarters, with growth averaging 43.5%.
  • Per Business Quant data, QTTB's Debt Ratio in the three quarters before Q1 2026 was 0.16 (Q4 2025), 0.19 (Q3 2025) and 0.19 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Q32 Bio 196.30 Mn -77.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.13
Dec 31, 2025 0.16
Sep 30, 2025 0.19
Jun 30, 2025 0.19
Mar 31, 2025 0.16
Dec 31, 2024 0.14
Sep 30, 2024 0.12
Jun 30, 2024 0.10
Mar 31, 2024 0.08
Dec 31, 2023 0.12
API Access

Q32 Bio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=QTTB&period=max&api_key=YOUR_API_KEY